Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology

Ann Joy Cheng, Li Chiu Chen, Kun Yi Chien, Yin Ju Chen, Joseph Tung Chieh Chang, Hung Ming Wang, Chun Ta Liao, I. How Chen

研究成果: 雜誌貢獻文章同行評審

129 引文 斯高帕斯(Scopus)


Background: There is no plasma marker for detecting oral cancer, one of the most frequent cancers worldwide. We developed a bead-based affinity- fractionated proteomic method to discover a novel plasma marker for oral cancer. Methods: Affinity purification of heparinized plasma with magnetic beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis were used to screen potential oral cancer markers. We compiled MS protein profiles for 57 patients with oral cancer and compared them with profiles from 29 healthy controls. The spectra were analyzed statistically using flexAnalysis™ and Clin-Prot™ bioinformatic software. In each MS analysis, the peak intensities of interest were normalized with an internal standard (adrenocorticotropic hormone 18-39). For identification, affinity bead-purified plasma protein was subjected to MALDI TOF/TOF analysis followed by Mascot identification of the peptide sequences and a search of the National Center for Biotechnology Information protein database. Results: To optimize MALDI-TOF analysis based on the best discriminator of the cancer and control spectra, copper-chelated beads were used for plasma protein profiling. The within- and between-run CVs for assays were

頁(從 - 到)2236-2244
期刊Clinical Chemistry
出版狀態已發佈 - 12月 2005

ASJC Scopus subject areas

  • 臨床生物化學


深入研究「Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology」主題。共同形成了獨特的指紋。